Frontiers in Immunology, 2026 Post-booster longitudinal plasma proteomic changes following BNT162b2 COVID-19 vaccination in Qatar Bentebbal S., Zaqout A., Meqbel B. et al. Olink Target 96Infectious DiseasesPathophysiologyPlasma | | | | |
Communications Medicine, 2026 Divergent inflammatory and neurology-related protein levels in long COVID following primary and breakthrough SARS-CoV-2 infections Bansal A., Olechnowicz S., Kiernan-Walker N. et al. Olink Target 96Infectious DiseasesPathophysiologyPlasma | | | | |
Circulation: Genomic and Precision Medicine, 2026 Associations of the
ICAM1
p.K56M HFpEF Risk Variant With Pericardial Adiposity and the Inflammatory Proteome Aneja A., Culler K., Ding J. et al. Olink Target 96Metabolic DiseasesCVDPathophysiologyPlasma | | | | |
Hypertension, 2026 Integrative Proteomic Profiling of Blood Pressure and Hypertension Aggarwal M., Joehanes R., Huan T. et al. Olink Explore 3072/384Olink Explore HTCVDPathophysiologyPlasma | | | | |
Nature Medicine, 2026 Genetic regulation across germline and somatic variation on the Y chromosome contributes to type 2 diabetes Sato G., Yamamoto Y., Sonehara K. et al. Olink Explore 3072/384Metabolic DiseasesAndrologyPathophysiologyPlasma | | | | |
International Journal of Molecular Sciences, 2026 Large-Scale Plasma Proteomics and Genetic Integration Uncover Novel Biological Pathways in Male Pattern Baldness Pan L., Li C., Moog P. et al. Olink Explore 3072/384AndrologyPathophysiologyPlasma | | | | |
Journal of Hazardous Materials Advances, 2026 Plasma proteomic signatures link environmental exposures to lung cancer risk Zhu Y., Wu Y., Tang Y. et al. Olink Explore 3072/384OncologyEnvironmental Health & ToxicologyPathophysiologyPlasma | | | | |
Nature, 2026 Thymic health and immunotherapy outcomes in patients with cancer Bernatz S., Prudente V., Pai S. et al. Olink Explore 3072/384ImmunotherapyOncologyPathophysiologyPlasma | | | | |
Thoracic Cancer, 2026 Blood Based Biomarkers for Predicting Treatment Response to Immune Checkpoint Inhibitors After EGFR ‐ TKI Resistance in Non‐Small Cell Lung Cancer Park M., Lim J., Park N. et al. Olink Target 96ImmunotherapyOncologyPatient StratificationPlasma | | | | |
JCO Oncology Advances, 2026 Tumor-Targeted IL-12 (PDS01ADC) With Hepatic Artery Infusion Pump Therapy for Colorectal Liver Metastases: Interim Analysis of a Nonrandomized Phase II Trial Eade A., Smith E., Monge C. et al. Olink Target 96ImmunotherapyOncologyPathophysiologyPlasma | | | | |
Journal of Inflammation Research, 2026 Identification of a Four-Biomarker Panel for the Diagnosis of Tuberculous Pleural Effusion Using Olink Proteomics Xing X., Guo C., Zhao G. et al. Olink Target 96Respiratory DiseasesInfectious DiseasesPatient StratificationPleural Effusion Fluid | | | | |
Metabolism, 2026 Large-scale plasma proteomics for predicting future cardiovascular and all-cause mortality among individuals with cardiovascular-kidney-metabolic syndrome stage 0–3 Weng B., Wei J., Chen H. et al. Olink Explore 3072/384CVDNephrologyMetabolic DiseasesPatient StratificationPlasma | | | | |
Frontiers in Immunology, 2026 Circulating IL-17A accumulation reflects effective target blockade with secukinumab in spondyloarthritis Martínez-Moreno J., Llamas-Urbano A., Romero-Zurita L. et al. Olink Target 48Immunological & Inflammatory DiseasesPathophysiologyPatient StratificationSerum | | | | |
Neuron, 2026 Sex-specific APOE4-dependent innate immunity regulates meningeal lymphatics, brain lipids, neuroinflammation, and cognition Delivanoglou N., Todd K., Almeida F. et al. Olink Target 48 MouseNeurologyPathophysiologyMouse Tissue Lysate | | | | |
European Journal of Applied Physiology, 2026 Acute responses of inflammatory markers, glucose, and myoglobin in blood following neuromuscular electrical stimulation Flodin J., Amiri P., Reitzner S. et al. Olink Target 96Metabolic DiseasesImmunological & Inflammatory DiseasesTechnical EvaluationBlood | | | | |
Brain, Behavior, & Immunity - Health, 2025 Plasma profiles of neurology-related proteins in at-risk mental state and first-episode psychosis: Associations with psychotic symptoms and cognitive performance Llaurador-Coll M., Montalvo I., Estrada F. et al. Olink Target 96NeurologyPathophysiologyPatient StratificationPlasma | | | | |
European Heart Journal, 2026 Silent plaque ruptures in non-obstructive lesions of non–infarct-related arteries: a multimodality, serial intracoronary imaging study Kakizaki R., Biccirè F., Losdat S. et al. Olink Target 96CVDPathophysiologyPlasma | | | | |
Cardiovascular Diabetology, 2026 Multiblock proteomic profiling identifies novel biomarkers linking prediabetes with preclinical atherosclerosis in apparently healthy adults Zieleniewska N., Jamiołkowski J., Kondraciuk M. et al. RevealMetabolic DiseasesCVDPathophysiologyPatient StratificationPlasma | | | | |
Metabolism, 2026 When the proteome meets the metabolome observational and Mendelian randomization analyses Zheng R., Delgado-Velandia M., Ärnlöv J. et al. Olink Target 96Olink Explore 3072/384Wider Proteomics StudiesPathophysiologyPlasma | | | | |
World Journal of Gastroenterology, 2026 Plasma proteomic profiling of gastric cancer: Super minimally invasive surgery
vs
organ-resection on trauma immunity Yuan Y., Chen Q., Xiao P. et al. Olink Target 96OncologySurgical ComplicationsPathophysiologyPlasma | | | | |